Publicaciones científicas

New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD

05-jun-2019 | Revista: The European Respiratory Journal

Seijo LM (1,2), Soriano JB (2,3), Peces-Barba G (2,4).

(1) Clínica Universidad de Navarra, Madrid, Spain.
(2) Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
(3) Hospital Universitario La Princesa, Madrid, Spain.
(4) IIS - Fundación Jiménez Díaz, Madrid, Spain.


Not long ago, chronic obstructive pulmonary disease (COPD) was considered a Cinderella, an unappealing disease lacking therapeutic options. It was also stigmatised as a consequence of the smoking habit that is a leading cause of COPD worldwide [1]. However, as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [2], and the joint American Thoracic Society/European Respiratory Society consensus documents suggest [3], COPD should be viewed as treatable and preventable, offering multiple opportunities for disease modification.

CITA DEL ARTÍCULO  Eur Respir J. 2019 Jun 5;53(6). pii: 1900717. doi: 10.1183/13993003.00717-2019

Nuestros autores